Your browser doesn't support javascript.
loading
HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC.
Dong, Jing; Zhang, Xueyuan; Du, Xingyu; Zou, Naiyi; Shen, Wenbin; Ma, Ming; Wang, Yaojie; Zhu, Shuchai.
Afiliação
  • Dong J; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
  • Zhang X; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
  • Du X; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
  • Zou N; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
  • Shen W; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
  • Ma M; Department of Clinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
  • Wang Y; Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
  • Zhu S; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
J Cancer ; 13(9): 2717-2726, 2022.
Article em En | MEDLINE | ID: mdl-35812184

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article